Searchable abstracts of presentations at key conferences in endocrinology

ea0063p877 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Accuracy of adrenal imaging studies in predicting histological tumor dimension following adrenalectomy

Alexandraki Krystallenia , Aggeli Chrysanthi , Antonopoulou Ioanna , Parianos Christos , Ntokos George , Pateas Konstantinos , Kaltsas Gregory , Zografos Georgios

Introduction: Although computed tomography (CT) is the best mean to identify adrenal neoplasms there is still controversy of the concordance of the estimated radiological and histological size of the lesion. Since the size of adrenal tumours is a major criterion for surgical excision, we investigated whether recent and more sophisticated imaging techniques, can more accurately predict tumor’s size.Methods: We have retrospectively analyzed a series o...

ea0049ep176 | Endocrine tumours and neoplasia | ECE2017

Large intestinal metaplasia is a precancerous lesion present in patients with gastric neuroendocrine neoplasms type 1

Boutzios Georgios , Alexandraki Krystallenia , Mavroeidi Vassiliki , Koukoulioti Eleni , Papanikolaou Ioannis , Kaltsas Gregory

Background: Intestinal metaplasia (IM) of the gastric mucosa is a relatively frequent precancerous lesion. The aim of the study was to assess the prevalence and the kind of IM and also to find parameters that could predict the presence of IM in gastric neuroendocrine neoplasms type 1 (GNEN1).Methods: Fifty-nine (45 females) patients with GNEN1 were retrospectively studied. All patients included in the study had positive parietal-cell antibodies. All pati...

ea0049ep1253 | Thyroid (non-cancer) | ECE2017

Long term effects of the less than total thyroidectomy: The experience of a tertiary care center

Boutzios Georgios , Garoufalia Zoe , Alexandraki Krystallenia , Kaltsas Gregory , Kouraklis Grigorios , Tsourouflis Gerasimos

Background and aims: Less than total thyroidectomy (lobectomy, partial or subtotal thyroidectomy) is used mainly to treat thyroid nodules, and/or hyperthyroidism. The aim of the study was to investigate the long term effects of less extensive surgical procedures. such as re-appearance of nodules and the need of thyroxin supplementation, or re-operation.Material and methods: Retrospective study in a tertiary Academic medical center. The study population c...

ea0041gp4 | Adrenal | ECE2016

The role of immunochemistry in the SDHx mutations in pheochromocytomas and paragangliomas

Angelousi Anna , Georgios Kyriakopoulos , Pavlos Constantinou , Georgios Zografos , Georgios Piaditis , Theodosia Xoreutaki , Dimitra Rontogianni , Gregory Kaltsas

Introduction: Early detection of succinate dehydrogenase complex (SDH) mutations in patients with pheochromocytoma and paragaglioma (PPC/PGL) has important implications as it is associated with increased risk for malignancy. The use of negative immunohistochemical (IHC) staining for SDH subunit B, D, A (SDHB/-D/-A) has been proposed as an indicator of SDHs mutation and as an effective substitute for the high-cost genetic screening of all of these genes.M...

ea0041gp170 | Receptors & Signalling | ECE2016

Altered exression of circadian clock genes in polyglandular autoimmune syndrome type III

Angelousi Anna , Nasiri-Ansari Narjes , Spilioti Eliana , Kalotychou Vasiliki , Chrousos George , Kaltsas Gregory , Kassi Eva

Introduction: CLOCK system is a highly conserved, ubiquitous molecular ‘clock’ which creates internal circadian rhythmicity under the influence of light/dark information. CLOCK system is regulated by the coordinated activation/inactivation of several transcription factors, including the CLOCK, the BMAL1 and other essential regulators, such as the Pers, Crys and RORs. The present study aimed to evaluate the circadian rhythm of clock-related genes expressed in patients...

ea0037ep704 | Pituitary: basic and neuroendocrinology | ECE2015

The higher gastrin levels were associated with better glycaemic control

Boutzios Georgios , Alexandraki Krystallenia , Moschouris Panagiotis , Lampropoulou Eleni , Evaggelatou Anastasia , Velidaki Antigoni , Kitsou Eufrosyni , Kaltsas Gregory

Background: Gastrin is an early incretin candidate, since it is released by oral glucose and potentiates the glucose-induced insulin secretion. It has been shown that only in hypoglycaemic or hyperglycaemic conditions gastrin release is influenced by changes in blood glucose and insulin concentrations.Aim: To evaluate whether there is a relation between fasting serum glucose and serum gastrin concentrations.Methods: Gastrin and glu...

ea0037ep1143 | Endocrine tumours | ECE2015

A case series of etomidate use in ACTH ectopic syndrome in endocrine neoplasms

Boutzios Georgios , Nikolopoulos Georgios , Alexandraki Krystallenia , Kaltsatou Maria , Chrysochoou Maria , Tsoli Marina , Kaltsas Gregory

Introduction: Etomidate is an imidazole derivative which inhibits several enzymatic steps (11β-hydroxylasey, 17β-hydroxylase, 17,20-lyase, cholesterol side-chain cleavage). Intravenous etomidate at sub-anaesthetic doses remains an important option when i.v. administration is required for rapid treatment of severely ill patients with hypercortisolaemia (Cushing’s syndrome, CS) and is almost always very effective.Case series: A 49-year-old w...

ea0035p537 | Endocrine tumours and neoplasia | ECE2014

Sunitinib induced hypocalcaemia during treatment of pancreatic neuroendocrine tumours

Alexandraki Krystallenia , Karnezis James , Kaltsatou Maria , Chatzellis Eleftherios , Tsoli Marina , Chrysochoou Maria , Boutzios Georgios , Kaltsas Gregory

Background: Although sunitinib, an oral multitargeted tyrosine kinase inhibitor of RET, VEGFR, PDGFR, c-KIT used for cancer treatment, has a reported prevalence of hypocalcemia of 35%, this has not been documented in pancreatic neuroendocrine tumour (pNETs).Methods: We present three, out of 12, patients with pNETs treated with sunitinib who developed grade 1, 2 and 4 hypocalcemia according Common Terminology Criteria for Adverse Events v3.0 (CTCAE) crite...

ea0035p598 | Endocrine tumours and neoplasia | ECE2014

Expression of somatostatin and dopamine receptors in neuroendocrine tumors: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores

Diakatou Evanthia , Tsolakis Apostolos , Alexandraki Krystallenia , Chatzellis Eleftherios , Leonti Anastasia , Kontogeorgos Georgios , Kaltsas Gregory

Background: The expression and/or co-expression of somatostatin (sstr1–5) and dopamine (DR) receptors in neuroendocrine tumors (NETS) is of clinical interest as their expression implies that NETS could be treated with combined targeted therapy. In addition, the expression of sstrs permits tumour visualization with radiolabelled sst analogs (111In-DTPA-OctreoScan).Methods: We analyzed preoperative Octreoscans findings (also graded for the ...

ea0035p608 | Endocrine tumours and neoplasia | ECE2014

Metastatic bone disease in patients with neuroendocrine tumors

Alexandraki Krystallenia , Chrysochoou Maria , Kaltsatou Maria , Chatzellis Eleftherios , Tsoli Marina , Boutzios Georgios , Thomas Dimitrios , Kaltsas Gregory

Objective: The prevalence of metastatic bone disease in patients with neuroendocrine tumours (NETs) and their response to first line treatment with biphosphonates.Methods: We studied 271 patients (141 females) with NETs: 54 gastric, nine duodenal, 102 pancreatic, 29 small intestine, 29 appendix, 14 colon, 15 lung, one thymic, 20 unknown primary and ten elsewhere. Since September 2012 all patients with NETs and bone metastases were recruited to receive 4 ...